Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind three-arm Phase II trial of Kangbingdu lozenges in acute upper respiratory infection (wind-heat pattern)
CTR20131812Phase 2Completed
- Sponsor
- Increas Biotech
- Start
- May 2014
- Countries
- 1
01
Overview
A Phase 2 trial of Kangbingdu lozenge in upper respiratory infection (URI), sponsored by Increas Biotech. Started May 2014; status: completed.
02
Drugs
Kangbingdu lozenge
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20131812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131812.